Metraipolis › archive › dc_6607a8a69712
Visual acuity and retinal thickness outcomes following anti-VEGF therapy in RVO: influence of early vs. delayed treatment — Europe PMC PMID:41832462
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41832462
- DOI
- 10.1186/s12886-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T21:34:03.833Z
- SHA-256 of the archived text
a986f4712251f3ba6b3d20f3aaac13c6591465ef95acec76e5e3ceff7bde18b9- Stable URL of this page
https://metraipolis.com/documento/dc_6607a8a69712
How to cite
Visual acuity and retinal thickness outcomes following anti-VEGF therapy in RVO: influence of early vs. delayed treatment — Europe PMC PMID:41832462 — Europe PMC (en), https://europepmc.org/article/MED/41832462 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6607a8a69712 (Metraipolis archive dc_6607a8a69712, sha256 a986f4712251f3ba6b3d20f3aaac13c6591465ef95acec76e5e3ceff7bde18b9)
BibTeX
@misc{dc6607a8a69712,
title = {Visual acuity and retinal thickness outcomes following anti-VEGF therapy in RVO: influence of early vs. delayed treatment — Europe PMC PMID:41832462},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41832462},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6607a8a69712; sha256 a986f4712251f3ba6b3d20f3aaac13c6591465ef95acec76e5e3ceff7bde18b9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41832462. Agents can read the archived copy with the MCP tool read_document.